Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans

INTRODUCTION: Recently it has been shown in animal models of amyotrophic lateral sclerosis (ALS) that stem cells significantly slow the progression of the disease and prolong survival. We have evaluated the feasibility and safety of a method of intraspinal cord implantation of autologous mesenchymal stem cells (MSCs) in a few well‐monitored patients with ALS. METHOD: Bone marrow collection was performed according to the standard procedure by aspiration from the posterior iliac crest. Ex vivo expansion of mesenchymal stem cells was induced according to Pittenger's protocol. The cells were suspended in 2 ml of autologous cerebrospinal fluid and transplanted into the spinal cord by a micrometric pump injector. RESULTS: No patient manifested major adverse events such as respiratory failure or death. Minor adverse events were intercostal pain irradiation (4 patients) which was reversible after a mean period of three days after surgery, and leg sensory dysesthesia (5 patients) which was reversible after a mean period of six weeks after surgery. No modification of the spinal cord volume or other signs of abnormal cell proliferation were observed. CONCLUSIONS: Our results appear to demonstrate that the procedures of ex vivo expansion of autologous mesenchymal stem cells and of transplantation into the spinal cord of humans are safe and well tolerated by ALS patients.

[1]  W. Piacibello,et al.  Isolation of human mesenchymal stem cells: bone marrow versus umbilical cord blood. , 2001, Haematologica.

[2]  I. Black,et al.  Adult rat and human bone marrow stromal cells differentiate into neurons , 2000, Journal of neuroscience research.

[3]  R. Sufit.  Issues in clinical trial design I , 1996, Neurology.

[4]  C. Verfaillie,et al.  Human Bone Marrow Stem Cells Exhibit Neural Phenotypes and Ameliorate Neurological Deficits after Grafting into the Ischemic Brain of Rats , 2002, Experimental Neurology.

[5]  W. Janssen,et al.  Adult Bone Marrow Stromal Cells Differentiate into Neural Cells in Vitro , 2000, Experimental Neurology.

[6]  A. Buchan,et al.  Transplantation of cultured human neuronal cells for patients with stroke , 2001, Neurology.

[7]  A. Björklund,et al.  Cell replacement therapies for central nervous system disorders , 2000, Nature Neuroscience.

[8]  I. Black,et al.  Adult bone marrow stromal stem cells express germline, ectodermal, endodermal, and mesodermal genes prior to neurogenesis , 2002, Journal of neuroscience research.

[9]  B. Vastag.  Stem cells step closer to the clinic: paralysis partially reversed in rats with ALS-like disease. , 2001, JAMA.

[10]  M. Filippi,et al.  Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS , 2001, Neurology.

[11]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[12]  T. Munsat.  Issues in clinical trial design I , 1996, Neurology.

[13]  O. Lindvall.  Prospects of transplantation in human neurodegenerative diseases , 1991, Trends in Neurosciences.

[14]  O. Lindvall,et al.  Cell Therapy and Transplantation in Parkinsons Disease , 2001, Clinical chemistry and laboratory medicine.

[15]  N. Ende,et al.  Human umbilical cord blood effect on sod mice (amyotrophic lateral sclerosis). , 2000, Life sciences.

[16]  N. Ende,et al.  The potential for the use of mononuclear cells from human umbilical cord blood in the treatment of amyotrophic lateral sclerosis in SOD1 mice. , 2000, Journal of medicine.

[17]  T. Holekamp,et al.  Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. K. Bubien,et al.  Differentiation of adult bone marrow stem cells into neuroprogenitor cells in vitro , 2002, Neuroreport.

[19]  I. Black,et al.  Adult rat and human bone marrow stromal stem cells differentiate into neurons. , 2001, Blood cells, molecules & diseases.

[20]  G. W. Huntley,et al.  Intracerebral transplantation of mesenchymal stem cells into acid sphingomyelinase-deficient mice delays the onset of neurological abnormalities and extends their life span. , 2002, The Journal of clinical investigation.

[21]  T. Kawase,et al.  Differentiation and Angiogenesis of Central Nervous System Stem Cells Implanted with Mesenchyme into Ischemic Rat Brain , 1999, Cell transplantation.

[22]  J. Heywood,et al.  Human intrathecal transplantation of peripheral blood stem cells in amyotrophic lateral sclerosis. , 2001, Journal of hematotherapy & stem cell research.

[23]  R. Barker,et al.  Neurodegeneration: a failure of neuroregeneration? , 2001, The Lancet.

[24]  C. Olanow,et al.  Transplantation of embryonic dopamine neurons for severe Parkinson's disease. , 2001, The New England journal of medicine.

[25]  M. Chopp,et al.  Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats , 2001, Journal of the Neurological Sciences.

[26]  P. Sanberg,et al.  Positive Effect of Transplantation of hNT Neurons (NTera 2/D1 Cell-Line) in a Model of Familial Amyotrophic Lateral Sclerosis , 2002, Experimental Neurology.

[27]  B. Vastag.  Stem Cells Step Closer to the Clinic , 2001 .

[28]  J. Mcdonald,et al.  Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord , 1999, Nature Medicine.

[29]  A. Björklund,et al.  Cell therapy in Parkinson's disease – stop or go? , 2001, Nature Reviews Neuroscience.

[30]  E. Scott,et al.  Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion , 2002, Nature.

[31]  P. Sanberg,et al.  Intraspinal implantation of hNT neurons into SOD1 mice with apparent motor deficit , 2001, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.